Howard W. Robin Sells 14,881 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 14,881 shares of Nektar Therapeutics stock in a transaction dated Monday, August 19th. The stock was sold at an average pr… [+3829 chars]

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
Psyence Group's NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones
Psyence Group's NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones

Prediction of antimicrobial resistance of Klebsiella pneumoniae from genomic data through machine learning
Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule